• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Intel Reportedly In Talks To Acquire Chip Production Company GlobalFoundries For USD 30 Billion

July 24, 2021 by Eddie Worrell Leave a Comment

Intel is working on its biggest deal ever as the company is reportedly in talks to acquire chip production company GlobalFoundries. People who are aware of the development said that if finalized, the deal would be worth around USD 20 billion. The deal is being worked upon under the leadership of Intel’s new chief executive officer Pat Gelsinger. He has been at the helm of the company for less than six months and moving ahead faster to get the business back on track. The company went through a lot lately and has not been able to perform as expected. This pushed Intel’s operation much below the innovative curve. Intel has been in the industry for almost five decades. From making the first commercialized central procession unit or CPU in the early 1970s to becoming that most trusted name in the world of chip-making, Intel has pulled everything well. But it is now facing tough competition in the proliferating chip space. Advanced Micro Devices (AMD) was once in the industry only to make sure that Intel doesn’t have a monopoly. But the Silicon Valley-based company is now struggling to survive against the underdog. AMD’s semiconductor technology is considered to be much advanced than Intel and is rapidly stealing the market share.

Intel’s new CEO knows that he needs to move fast in order to get the company’s technology and capacity up to the required standards if he wants to regain the lost reputation of the company. Intel has long been considered to be the best and most trusted integrated device manufacturer (IDM). Intel is not going to have many benefits in terms of technological development if the deal with GlobalFoundries is finalized. However, the deal will immediately help Intel increase the manufacturing capacity for third-party and internal use. This is because GlobalFoundries stopped working on advanced chips in 2018. Advanced chips are less than 10 nanometers in size. Manufacturing these chips requires a lot of innovations and the cost of it was getting too high for the company. Especially after the margin pinching competition escalated among competitors. The company is now working as a commodity business and has focused on ‘trailing-edge processes. Also, the company has found itself in a comfortable position because of the increased demand for chips in the automotive amid a sudden global shortage. This is probably the reason why Intel is keen on sealing the deal.

The deal is also fuelled by the USD 52 billion bills that got passed by the Senate last month. The bill is aimed at boosting the production of semiconductors. The bill wants to reduce the dependency on foreign chipmakers like Taiwan Semi or TSM. The Taiwanese company is manufacturing around 57 percent of the semiconductors annually produced around the world. And this is why most tech innovators heavily depend on TSM. If the deal is finalized, this trailing-edge chipmaker is likely to add on USD 6 billion in revenue of Intel this year. This is why it is not sure that whether Intel would be upgrading these facilities or would be focusing on increasing the capacity. Integrate new technologies would help Intel to compete with the companies like Samsung and TSM. But the probabilities are that Intel would just is a foundry. The companies must be now keeping their fingers crossed as they don’t want the deal to face any anti-trust complaint.

Eddie Worrell
Eddie Worrell

Related posts:

  1. Kaiser Permanente Workers Postpone 5-Day Statewide Strike As Death Of CEO Bernard Tyson
  2. President Trump decides to meet Russia’s Lavrov at the White House
  3. FDA Postponed Foreign Reviews Citing Coronavirus Epidemic
  4. 28 Individuals Killed in Eastern Russian Plane Crash

Filed Under: Business

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • “Exceptional” 5.5-Million-Light-Year-Long Cosmic Structure Appears To Be Rotating, Challenging Current Models Of The Universe
  • How A Mystery Volcano Sparked The Black Death In The 14th Century
  • A Strange New Species Of Bird Has Worrying Similarities To The Doomed Dodo
  • Darkest Fabric Ever Made – Inspired By Birds-Of-Paradise – Creates The Ultimate Little Black Dress
  • This Guy’s Head Was Bitten By A Lion 6,000 Years Ago – But He Survived
  • 12 Former FDA Heads Call Out FDA’s Leaked Memo Claiming COVID-19 Vaccines Killed Children In Bid To Change Policy
  • Hidden Features In Our Galaxy Discovered By Studying The Milky Way From The Inside Out
  • Why Does My Belly Button Smell?
  • 2,500-Year-Old Chronicle Is Oldest Known Record Of A Total Solar Eclipse And Reveals Some Surprises
  • RIP Claude: San Francisco’s Iconic Albino Alligator Dies Aged 30
  • Nitrous Oxide: Inhaling “Laughing Gas” Could Be Surprisingly Effective For Treating Severe Depression
  • JWST Discovers A Milky Way-Like Spiral Galaxy Where It Shouldn’t Exist
  • World’s Largest Dinosaur Tracksite Has At Least 16,600 Footprints And Sets Many World Records
  • Interstellar Comet 3I/ATLAS Will Make Its Closest Approach To Earth This Month, Just 270 Million Kilometers Away
  • How Does Time Pass On Mars? For The First Time, We Have A Precise Answer
  • Is This How The Voynich Manuscript Was Made? A New Cipher Offers Fascinating Clues
  • An Extremely Rare And Beautiful “Meat-Eating” Plant Has Been Found Miles From Its Known Home
  • Scheerer Phenomenon: Those White Structures You See When You Look At The Sky May Not Be “Floaters”
  • The Science Of Magic At CURIOUS Live: Psychologist Dr Gustav Kuhn On Using Magic To Study The Human Mind
  • Around 5 Percent Of Cancers Are Of “Unknown Primary”. Could A New Blood Test Track Them Down?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version